Recombinant human erythropoietin-induced erythropoiesis regulates hepcidin expression over iron status in the rat

Blood Cells, Molecules, and Diseases

Volumn 59, Issue , 2016, Pages 63-70

  Ribeiro, Sandra ^a   Garrido, Patrícia ^b   Fernandes, João ^b,c   Rocha, Susana ^a   Rocha Pereira, Petronila ^a,d   Costa, Elísio ^a   Belo, Luís ^a   Reis, Flávio ^b,c   Santos Silva, Alice ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d UNIVERSITY OF BEIRA INTERIOR   (Portugal)

Author keywords

Erythropoiesis; Hepcidin; Iron; Matriptase 2; Transferrin saturation

Indexed keywords

ERYTHROPOIETIN; HEPCIDIN; IRON; MATRIPTASE 2; MEMBRANE PROTEIN; RECOMBINANT PROTEIN; SERINE PROTEINASE; TRANSFERRIN;

ANIMAL; BIOSYNTHESIS; DOSE RESPONSE; DRUG EFFECTS; ERYTHROPOIESIS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; PHYSIOLOGY; RAT; WISTAR RAT;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROPOIESIS; ERYTHROPOIETIN; GENE EXPRESSION REGULATION; HEPCIDINS; HUMANS; IRON; MALE; MEMBRANE PROTEINS; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; SERINE ENDOPEPTIDASES; TRANSFERRIN;

EID: 84966393581     PISSN: 10799796     EISSN: 10960961     Source Type: Journal    
DOI: 10.1016/j.bcmd.2016.04.008     Document Type: Article

References (30)

1. Anderson G.J., Frazer D.M., McLaren G.D. Iron absorption and metabolism. Curr. Opin. Gastroenterol. 2009, 25:129-135.
2. Nemeth E., Tuttle M.S., Powelson J., Vaughn M.B., Donovan A., Ward D.M., Ganz T., Kaplan J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004, 306:2090-2093.
3. Ganz T., Nemeth E. Hepcidin and iron homeostasis. Biochim. Biophys. Acta 1823, 2012:1434-1443.
4. European Medicines Agency. Summary of product characteristics. Available at ([acessed on 15-12-2015]). http://www.ema.europa.eu/ema/.
5. Arcasoy M.O. The non-haematopoietic biological effects of erythropoietin. Br. J. Haematol. 2008, 141:14-31.
6. Egger K., Clemm von Hohenberg C., Schocke M.F., Guttmann C.R., Wassermann D., Wigand M.C., Nachbauer W., Kremser C., Sturm B., Scheiber-Mojdehkar B., Kubicki M., Shenton M.E., Boesch S. White matter changes in patients with friedreich ataxia after treatment with erythropoietin. J. Neuroimaging 2014, 24:504-508.
7. Tsai T.H., Lu C.H., Wallace C.G., Chang W.N., Chen S.F., Huang C.R., Tsai N.W., Lan M.Y., Sung P.H., Liu C.F., Yip H.K. Erythropoietin improves long-term neurological outcome in acute ischemic stroke patients: a randomized, prospective, placebo-controlled clinical trial. Crit. Care 2015, 19:49.
8. Hamed S., Bennett C.L., Demiot C., Ullmann Y., Teot L., Desmouliere A. Erythropoietin, a novel repurposed drug: an innovative treatment for wound healing in patients with diabetes mellitus. Wound Repair Regen. 2014, 22:23-33.
9. Lund A., Lundby C., Olsen N.V. High-dose erythropoietin for tissue protection. Eur. J. Clin. Investig. 2014, 44:1230-1238.
10. Frazer D.M., Wilkins S.J., Darshan D., Badrick A.C., McLaren G.D., Anderson G.J. Stimulated erythropoiesis with secondary iron loading leads to a decrease in hepcidin despite an increase in bone morphogenetic protein 6 expression. Br. J. Haematol. 2012, 157:615-626.
11. Vokurka M., Krijt J., Sulc K., Necas E. Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis. Physiol. Res. 2006, 55:667-674.
12. Diaz V., Gammella E., Recalcati S., Santambrogio P., Naldi A.M., Vogel J., Gassmann M., Cairo G. Liver iron modulates hepcidin expression during chronically elevated erythropoiesis in mice. Hepatology 2013, 58:2122-2132.
13. Hillman R.S., Finch C.A. Red Cell Manual 1985, Davis Company, Philadephia. fifth ed.
14. Garrido P., Ribeiro S., Fernandes J., Vala H., Bronze-da-Rocha E., Rocha-Pereira P., Belo L., Costa E., Santos-Silva A., Reis F. Iron-hepcidin dysmetabolism, anemia and renal hypoxia, inflammation and fibrosis in the remnant kidney rat model. PLoS One 2015, 10:e0124048.
15. Ford J. Red blood cell morphology. Int. J. Lab. Hematol. 2013, 35:351-357.
16. Beguin Y. Erythropoietin and platelet production. Haematologica 1999, 84:541-547.
17. Pinto J.P., Ribeiro S., Pontes H., Thowfeequ S., Tosh D., Carvalho F., Porto G. Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBPalpha. Blood 2008, 111:5727-5733.
18. Liu Q., Davidoff O., Niss K., Haase V.H. Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis. J. Clin. Invest. 2012, 122:4635-4644.
19. Gammella E., Diaz V., Recalcati S., Buratti P., Samaja M., Dey S., Noguchi C.T., Gassmann M., Cairo G. Erythropoietin's inhibiting impact on hepcidin expression occurs indirectly. Am. J. Phys. Regul. Integr. Comp. Phys. 2015, 308:R330-R335.
20. Tanno T., Bhanu N.V., Oneal P.A., Goh S.H., Staker P., Lee Y.T., Moroney J.W., Reed C.H., Luban N.L., Wang R.H., Eling T.E., Childs R., Ganz T., Leitman S.F., Fucharoen S., Miller J.L. High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat. Med. 2007, 13:1096-1101.
21. Tanno T., Porayette P., Sripichai O., Noh S.J., Byrnes C., Bhupatiraju A., Lee Y.T., Goodnough J.B., Harandi O., Ganz T., Paulson R.F., Miller J.L. Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells. Blood 2009, 114:181-186.
22. Kautz L., Jung G., Valore E.V., Rivella S., Nemeth E., Ganz T. Identification of erythroferrone as an erythroid regulator of iron metabolism. Nat. Genet. 2014, 46:678-684.
23. Kautz L., Jung G., Du X., Gabayan V., Chapman J., Nasoff M., Nemeth E., Ganz T. Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of beta-thalassemia. Blood 2015, 126:2031-2037.
24. Jelkmann W. Regulation of erythropoietin production. J. Physiol. 2011, 589:1251-1258.
25. Rishi G., Wallace D.F., Subramaniam V.N. Hepcidin: regulation of the master iron regulator. Biosci. Rep. 2015, 35:e00192.
26. Gkouvatsos K., Papanikolaou G., Pantopoulos K. Regulation of iron transport and the role of transferrin. Biochim. Biophys. Acta 1820, 2012:188-202.
27. Frýdlová J., Přikryl P., Truksa J., Falke L.L., Du X., Gurieva I., Vokurka M., Krijt J. Effect of erythropoietin, iron deficiency and iron overload on liver matriptase-2 (TMPRSS6) protein content in mice and rats. PLoS One 2016, 11(2):e0148540.
28. Trinder D., Baker E. Transferrin receptor 2: a new molecule in iron metabolism. Int. J. Biochem. Cell Biol. 2003, 35:292-296.
29. Ginzburg Y., Rivella S. Beta-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism. Blood 2011, 118:4321-4330.
30. Guimaraes J.S., Cominal J.G., Silva-Pinto A.C., Olbina G., Ginzburg Y.Z., Nandi V., Westerman M., Rivella S., de Souza A.M. Altered erythropoiesis and iron metabolism in carriers of thalassemia. Eur. J. Haematol. 2015, 94:511-518.